Swathy, Babu and Saradalekshmi, K R and Indu V, Nair and Moinak , Banerjee (2017) Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs. Epigenomics, 9 (6). pp. 811-821. ISSN 1750-192X

Text Pharmacoepigenomic responses of(Epigenomics).pdf Restricted to Registered users only Download (918Kb) | Request a copy

Abstract

It is imperative to differentiate the role of host epigenetics from pharmacoepigenetics in resolving therapeutic response. Therefore, the objective was to identify how antipsychotic drugs influence epigenetic response on pharmacogenes. MATERIALS & METHODS: The study design was based on in vitro evaluation of pharmacoepigenetic response of haloperidol, clozapine and olanzapine. Post antipsychotic treatment, the alterations in expression of ABCB1, CYP1A2 and CYP3A4 were monitored, and followed up by promoter methylation and their target miRNA expression studies. Critical observations were followed up in a restrictive clinical setting. RESULTS: Under in vitro conditions increased expression of ABCB1, CYP1A2 and CYP3A4 was observed which seems to be regulated by miR-27a and miR-128a and not by methylation. A similar pattern was observed in clinical setting with ABCB1, which was reflective of good therapeutic response. CONCLUSION: The study demonstrates that antipsychotic drugs can influence miRNA-mediated epigenetic response in pharmacogenes resulting in modulating therapeutic response.

Item Type:	Article
Uncontrolled Keywords:	antipsychotic drugs; epigenetics; gene expression; miRNA; pharmacoepigenetics; pharmacogenes; schizophrenia
Subjects:	Human Molecular Genetics
Depositing User:	Central Library RGCB
Date Deposited:	21 Jun 2018 09:06
Last Modified:	21 Jun 2018 09:07
URI:	http://rgcb.sciencecentral.in/id/eprint/618

Actions (login required)

View Item